MedTrace Logo

Evaluation of a Breast Double Block Analgesia for the Mastectomy With Radical Axillary Lymphadenectomy Surgery

NCT03177733 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2018-11-28

No results posted yet for this study

Summary

This study evaluates the efficacy of the the pecto-intercostal fascial plane block (PIF block) for the anesthesia of the intercostal nerves anterior branches and assesses the association of the serratus block with a PIF block for the breast surgery.

To obtain a correct prospective clinical trial completion we have to begin a new series of inclusion.

Conditions

  • Mastectomy

Interventions

PROCEDURE

Evaluation of a breast double block

we made an association of the serratus block and the PIF block, which allows for a complete block of both the laterals branches of intercostal nerves (with the serratus block) and of anterior branches of intercostal nerves (with the PIF block). Therefore, this association of blocks may lead to a complete analgesia of the breast, while the serratus block alone only allows for an analgesia of the lateral part of the breast. The objective is to analyze this technique through a collection form that evaluates the satisfaction and post-operative morphine consumption of women receiving this association before a general anesthesia for a unilateral mastectomy with homolateral total lymphadenectomy. This is a purely observational study that assesses our current practice in this type of surgery.

Sponsors & Collaborators

  • Maison de Santé Prostestante de Bordeaux Bagatelle

    lead OTHER

Principal Investigators

  • Claude-charles Balick-weber · Maison de Santé Protestante de Bordeaux-Bagatelle

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2018-06-01
Completion
2018-07-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03177733 on ClinicalTrials.gov